Dr. Avgeropoulos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1400 S Orange Ave
Orlando, FL 32806Phone+1 407-648-3800Fax+1 407-425-5203
Education & Training
Massachusetts General HospitalFellowship, Neuro-Oncology, 1997 - 1999
Yale-New Haven Medical CenterFellowship, Neuropathology, 1996 - 1997
Medical University of South CarolinaResidency, Neurology, 1992 - 1996
Spartanburg Medical CenterInternship, Transitional Year, 1991 - 1992- Medical University of South CarolinaClass of 1991
Certifications & Licensure
FL State Medical License 1999 - 2026
NC State Medical License 2000 - 2004
CT State Medical License 1996 - 1997
SC State Medical License 1992 - 1996- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Start of enrollment: 2009 Jun 01
- A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Start of enrollment: 2011 Dec 01
- Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM) Start of enrollment: 2017 Sep 21
- Join now to see all
Publications & Presentations
PubMed
- 14 citationsCerebral amyloidoma mimicking intracranial tumor: a case report.Danny Landau, Nicholas G. Avgeropoulos, Joe Ma
Journal of Medical Case Reports. 2010-09-20 - 56 citationsGlioblastoma: background, standard treatment paradigms, and supportive care considerations.Susan V. Ellor, Teri Ann Pagano-Young, Nicholas Avgeropoulos
The Journal of Law, Medicine & Ethics. 2014-06-01 - 37 citationsHealth-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared ...Jay-Jiguang Zhu, Petya Demireva, Andrew A. Kanner, Susan C. Pannullo, Maximilian Mehdorn
Journal of Neuro-Oncology. 2017-08-28
Press Mentions
The University of Florida Investigator Leads Presentation of Immunomic Therapeutics Clinical DataNovember 23rd, 2019
Ground Rounds January 2012December 29th, 2011
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
